Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Advances in botulinum toxin applications].

P Zaleski1

  • 1Oddział Neurologii Szpitala Grochowskiego.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cloning of the Haemophilus influenzae Dam methyltransferase and analysis of its relationship to the Dam methyltransferase encoded by the HP1 phage.

Acta biochimica Polonica·2002
Same author

Iron content in rats' teeth in glucocorticoid-induced osteoporosis.

Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina·2002
Same author

The case of low symptoms carotid cavernous fistula.

Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina·2002
Same author

[Melatonin in sleep rhythm disorders after cerebral stroke].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego·2000
Same author

[Electric stimulation in receptor disorders of the ear (preliminary report)].

Vestnik otorinolaringologii·1983

Botulinum toxin type A, a potent neurotoxin from Clostridium botulinum, blocks nerve signals to muscles. It is increasingly used to treat muscle disorders and offers analgesic effects.

Area of Science:

  • Neuroscience
  • Microbiology
  • Pharmacology

Context:

  • Botulinum toxin type A is derived from the anaerobic bacterium Clostridium botulinum.
  • It is recognized as one of the most potent toxins known.
  • The toxin functions by binding to motor nerve end-plates, inhibiting acetylcholine release and inducing presynaptic neuromuscular blockade.

Purpose:

  • To explore the therapeutic applications of Botulinum toxin type A.
  • To highlight its efficacy in treating disorders of excessive or inappropriate muscle contraction.
  • To discuss its emerging roles in managing various neurological and physiological conditions.

Summary:

  • Botulinum toxin type A is increasingly utilized for treating conditions such as stroke, cerebral palsy, and multiple sclerosis.

Related Experiment Videos

  • It offers a novel therapeutic strategy for dystonias.
  • The toxin has also shown a notable analgesic effect and is being investigated for treating tics, tremors, hyperhidrosis, and myoclonus.

    • Impact:

    • Botulinum toxin type A represents a significant advancement in managing neuromuscular disorders.
    • Its applications extend beyond muscle contraction control to pain management.
    • The toxin's versatility supports its growing importance in clinical practice for a range of conditions.